A board to discuss future MS therapies in early stage (Phase I or II) trials.


Postby bromley » Wed May 24, 2006 3:22 am


I think the following can be moved from Phase I to Phase II.


Cambrex to Produce Serum for Trial

Cambrex to Make Serum for Merrimack Pharmaceuticals Autoimmune Disease Study.

Cambrex Corp. said Tuesday one of its subsidiaries will produce a serum for a Merrimack Pharmaceuticals clinical study on autoimmune disease treatments.

The subsidiary, Cambrex Bio Science Hopkinton Inc., will produce trial quantities of Merrimack's lead drug candidate, MM-093, for the Phase II study. Privately held, Cambridge, Mass.-based Merrimack is conducting the study to determine the serum's effectiveness on a range of autoimmune diseases including rheumatoid arthritis, multiple sclerosis and psoriasis.

Terms of the deal were not disclosed.

Cambrex and its subsidiaries focus on products and services for the drug-discovery industry.

Source: Yahoo Finance Copyright © 2006 The Associated Press.
User avatar
Family Elder
Posts: 1888
Joined: Fri Sep 10, 2004 3:00 pm


Postby dignan » Wed May 24, 2006 8:26 am

I'm not sure. It's in phase II already for RA and psoriasis, but not for MS I think...
User avatar
Family Elder
Posts: 1608
Joined: Wed Aug 11, 2004 3:00 pm

Return to Drug Pipeline

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service